Amyloidosis and Crohn's disease

被引:0
|
作者
Guardiola Arevalo, Antonio [1 ]
Alcantara Torres, Mariano [1 ]
Valle Munoz, Julio [1 ]
Lorente Poyatos, Rufo Humberto [4 ]
Romero Gutierrez, Marta [1 ]
Rodriguez Merlo, Rufo [2 ]
Perez Martinez, Alejandro [3 ]
Carrobles Jimenez, Jose Maria [1 ]
机构
[1] Hosp Virgen de la Salud, Serv Aparato Digest, Toledo 45004, Spain
[2] Hosp Virgen de la Salud, Serv Anat Patol, Toledo 45004, Spain
[3] Hosp Virgen de la Salud, Serv Radiodiagnost, Toledo 45004, Spain
[4] Hosp Gen Ciudad Real, Serv Aparato Digest, Ciudad Real, Spain
关键词
Amyloidosis; Secondary amyloidosis; Inflammatory bowel disease; Crohn's disease; Nephrotic syndrome; Renal failure; INFLAMMATORY-BOWEL-DISEASE; ANTI-TNF-ALPHA; SECONDARY AMYLOIDOSIS; SYSTEMIC AMYLOIDOSIS; RENAL AMYLOIDOSIS; NEPHROTIC SYNDROME; INFLIXIMAB; PATIENT; REGRESSION; RESOLUTION;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Secondary amyloidosis is a rare but serious complication of inflammatory bowel disease that may influence the prognosis even more than the underlying disease. Due to a better knowledge of the association of secondary amyloidosis to inflammatory bowel disease, early diagnosis of this complication is becoming more frequent, but it s treatment continues to pose a challenge. We report 4 cases of patients with Crohn's disease and amyloidosis diagnosed in the inflammatory bowel disease Units of Tole- do and Ciudad Real, which represent 0.68% of the patients with Crohn's disease of our health areas. There have been not cases of amyloidosis in patients with ulcerative colitis. In our 4 patients the secondary amyloidosis was clearly related to Crohn's disease, which was often of fistulising type. The predominant clinical picture of amyloidosis was nephrotic syndrome. The patients responded to medical and surgical treatment of Crohn's disease and colchicine, which improved renal function in all cases except in one who required kidney transplantation.
引用
收藏
页码:268 / 274
页数:7
相关论文
共 50 条
  • [31] New biologic therapeutics for ulcerative colitis and Crohn's disease
    Mozaffari, Shilan
    Nikfar, Shekoufeh
    Abdolghaffari, Amir Hossein
    Abdollahi, Mohammad
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (05) : 583 - 600
  • [32] Brain Abscesses in Crohn's Disease as a Complication of Infliximab Therapy
    Mansour, Mahmoud M.
    Mubarak, Muhammad
    Chela, Harleen
    Ghouri, Yezaz A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [33] Infliximab use in Crohn's disease
    Bewtra, M
    Lichtenstein, GR
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (04) : 589 - 599
  • [34] Ustekinumab for the treatment of Crohn's disease
    Khanna, Reena
    Feagan, Brian G.
    IMMUNOTHERAPY, 2013, 5 (08) : 803 - 815
  • [35] Vedolizumab in the treatment of Crohn's disease
    Gisbert, Javier P.
    Domenech, Eugeni
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2015, 38 (05): : 338 - 348
  • [36] Initiating Azathioprine for Crohn's Disease
    Levesque, Barrett G.
    Loftus, Edward V., Jr.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (05) : 460 - 465
  • [37] Conventional Therapies for Crohn's Disease
    Rolak, Stacey
    V. Kane, Sunanda
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2022, 51 (02) : 271 - 282
  • [38] Treatment Perspectives in Crohn's Disease
    Vetter, Marcel
    Neurath, Markus F.
    DIGESTION, 2018, 98 (03) : 135 - 142
  • [39] Intestinal Amyloidosis in A Patient with Crohn's Disease: A Rare Case Report
    Christy, Kezia
    Hebert, Harold
    Purnomo, Sugiharto
    Tenggara, Riki
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 802 - 802
  • [40] Successful Use of Maintenance Infliximab for Nephropathy in a Patient with Secondary Amyloidosis Complicating Crohn's Disease
    Tada, Yasumasa
    Ishihara, Shunji
    Ito, Takafumi
    Matsui, Kosuke
    Sonoyama, Hiroki
    Oka, Akihiko
    Kusunoki, Ryusaku
    Fukuba, Nobuhiko
    Mishima, Yoshiyuki
    Oshima, Naoiki
    Moriyama, Ichiro
    Yuki, Takafumi
    Kawashima, Kousaku
    Sato, Shuichi
    Adachi, Kyoichi
    Ikeuchi, Hiroki
    Kinoshita, Yoshikazu
    INTERNAL MEDICINE, 2013, 52 (17) : 1899 - 1902